Project Grant R01HL180509
Award Date 9/1/26
Completion Date 5/31/31
Dollars Obligated $769K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Boulder, CO 80309, USA
Similar Awards
- The National Institute for Occupational Safety and Health, part of the Centers for Disease Control and Prevention within the Department of Health and Human Services, awarded $174,617 to the University of Oklahoma Health Sciences Center on September 1, 2026, under the Occupational Safety and Health Program (CFDA 93.262) to assess occupational health risks and exposures in the cannabis industry and develop evidence-based approaches to worker safety. The award is a project grant with a period of...
- The National Institute on Drug Abuse, a component of the Department of Health and Human Services National Institutes of Health, awarded $703,662 to The Regents Of The University Of Colorado (doing business as University Of Colorado-Denver) on July 15, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to investigate prenatal cannabis exposure and child growth through examination of angiogenic and adipogenic pathways in perinatal tissues. The research combines large-scale...
- The National Institute on Drug Abuse awarded The Regents of the University of Colorado, doing business as University of Colorado-Denver, $496,402 on April 15, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) for a two-year project grant (R21DA065027) running through March 31, 2028. The award funds rigorous assessment of cannabis detection technologies to address impaired driving and public safety concerns. The research compares the performance of two breath-sampling devices...
- The Department of Health and Human Services Centers for Disease Control and Prevention (National Institute for Occupational Safety and Health) awarded The Regents of the University of Colorado, doing business as University of Colorado-Denver, $195,000 on September 1, 2026, under the Occupational Safety and Health Program (CFDA 93.262) to investigate mechanisms of thyroid carcinogenesis in agricultural workers exposed to glyphosate. The project grant funds research examining how glyphosate...
- The National Institute on Drug Abuse awarded The Regents of the University of California, San Francisco $246,000 on September 1, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to investigate the concurrent use of cannabis and stimulant medications on cardiovascular disease risk. The research will evaluate whether cannabis smoking and prescribed stimulant medication used together exert additive or synergistic effects on cardiovascular function and circulating biomarkers of...
- The National Heart Lung and Blood Institute awarded The Johns Hopkins University $783,962 on July 15, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to investigate indoor air quality interventions targeting cardiovascular health in patients with chronic obstructive pulmonary disease. The research, titled "Clean Air Heart 2: Targeting Indoor Air Quality to Improve Cardiovascular Health in COPD," addresses the elevated cardiovascular disease mortality risk in COPD...
- The National Heart, Lung, and Blood Institute awarded Cedars-Sinai Medical Center $854,391 on September 1, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to investigate the role of the endocannabinoid system in metabolic disease progression and associated cardiovascular risk. The research examines how circulating endocannabinoid species, including anandamide and 2-arachidonoylglycerol, contribute to the parallel progression of obesity to diabetes and the accompanying two-...
- The National Institute on Drug Abuse awarded Carnegie Mellon University $191,250 on September 1, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to investigate THC exposure and inhibitory circuit plasticity in the neocortex. The research examines acute and long-term effects of tetrahydrocannabinol (THC), the main psychoactive component of cannabis, on neocortical interneurons expressing the highest levels of cannabinoid receptors in the mammalian brain. The project will...
- The National Heart, Lung, and Blood Institute awarded the Trustees of Boston University $712,630 on August 1, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to investigate functional heterogeneity of alveoli and early responses to airborne agents. The recipient will develop and apply the Crystal Ribcage, a novel intravital imaging platform, to visualize real-time, high-resolution dynamics of the intact, ventilating lung. The research will define the anatomy, physiology,...
- The National Institute on Drug Abuse (NIDA) awarded The Johns Hopkins University $718,124 on September 15, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to investigate chronic cannabinoid vapor exposure effects on the brain and behavior. The research examines whether repeated exposure to vaporized delta-9-tetrahydrocannabinol (THC) causes lasting behavioral and neurological alterations in adult male and female rats, including disrupted neural connectivity, white matter...